Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Corneal Neovascularization

• The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization
• Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment
• An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization
• Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization
• Strategies for Management of Corneal Neovascularisation
• Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions
• A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
• Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea
• Treatment of Corneal Neovascularization With Topical Pazopanib
• Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
• Bevacizumab for the Treatment of Corneal Neovascularization
• Topical IL-1-Ra for Treatment of Corneal Neovascularization
• The Effect of Bevacizumab on Corneal Neovascularization
• Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery
• Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)
• Topical Avastin for Treatment of Corneal Neovascularization
• Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization
• Corneal Thinning During Topical Bevacizumab Therapy
• Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization
• Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization